The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific Antibodies

被引：2
|
作者：
Nath, Karthik [1 ]
Mailankody, Sham [1 ,2 ,3 ]
Usmani, Saad Z. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Cellular Therapy Serv, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, New York, NY USA
[3] Weill Cornell Med Coll, Dept Med, New York, NY USA
[4] Mem Sloan Kettering Cance, Adult Bone Marrow Transplant Serv, New York, NY USA
[5] 30 East 74th St,Room 20-228, New York, NY 10021 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 06期
关键词：
CAR T-cell therapy; Bispecific antibodies; Immunotherapeutic agents; Multiple myeloma; MULTIPLE-MYELOMA; MATURATION ANTIGEN; PLUS LENALIDOMIDE; PHASE-3; RISK; BCMA;
D O I：
10.1016/j.hoc.2023.05.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1201 / 1214
页数：14
相关论文
共 50 条
  • [31] Cardiovascular Toxicities with Chimeric Antigen Receptor T-cell Therapy
    Gill, Jashan
    CURRENT CARDIOLOGY REVIEWS, 2023, 19 (01) : 54 - 54
  • [32] Chimeric Antigen Receptor (CAR) T-Cell Therapy in Hematologic Malignancies: Clinical Implications and Limitations
    Bluem, Philipp
    Kayser, Sabine
    CANCERS, 2024, 16 (08)
  • [33] Chimeric Antigen Receptor T Cell Therapy and Its Significance in Multiple Myeloma
    Padda, Jaskamal
    Khalid, Khizer
    Zubair, Ujala
    Peethala, Mounika M.
    Kakani, Varsha
    Goriparthi, Lakshmi
    Almanie, Abdulelah H.
    Cooper, Ayden Charlene
    Jean-Charles, Gutteridge
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [34] Clinical data, limitations and perspectives on chimeric antigen receptor T-cell therapy in multiple myeloma
    Beauvais, David
    Danhof, Sophia
    Hayden, Patrick J.
    Einsele, Hermann
    Yakoub-Agha, Ibrahim
    CURRENT OPINION IN ONCOLOGY, 2020, 32 (05) : 418 - 426
  • [35] The evolving role of allogeneic haematopoietic cell transplantation in the era of chimaeric antigen receptor T-cell therapy
    Dholaria, Bhagirathbhai
    Savani, Bipin N.
    Huang, Xiao-Jun
    Nagler, Arnon
    Perales, Miguel-Angel
    Mohty, Mohamad
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (06) : 1060 - 1075
  • [36] Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon
    Martino, Massimo
    Naso, Virginia
    Loteta, Barbara
    Canale, Filippo Antonio
    Pugliese, Marta
    Alati, Caterina
    Musuraca, Gerardo
    Nappi, Davide
    Gaimari, Anna
    Nicolini, Fabio
    Mazza, Massimiliano
    Bravaccini, Sara
    Derudas, Daniele
    Martinelli, Giovanni
    Cerchione, Claudio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [37] Sex Differences in Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Tan, Jia Yi
    Yeo, Yong Hao
    Kin, Hermon Wong Kha
    Ang, Qi Xuan
    Chisti, Mohammad Muhsin
    Ezekwudo, Daniel
    Hilal, Talal
    CANCER MEDICINE, 2025, 14 (06):
  • [38] Chimeric antigen receptor T-cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice
    Parikh, Rujul H.
    Lonial, Sagar
    CA-A CANCER JOURNAL FOR CLINICIANS, 2023, 73 (03) : 275 - 285
  • [39] Demographic differences among patients treated with chimeric antigen receptor T-cell therapy in the United States
    Emole, Josephine
    Lawal, Odunayo
    Lupak, Oleksandra
    Dias, Ajoy
    Shune, Leyla
    Yusuf, Korede
    CANCER MEDICINE, 2022, 11 (23): : 4440 - 4448
  • [40] Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies
    Kampouri, Eleftheria
    Little, Jessica S.
    Rejeski, Kai
    Manuel, Oriol
    Hammond, Sarah P.
    Hill, Joshua A.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25
12345